Free press releases distribution network?

Agency / Source: Randox Laboratories Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Biochip Array Technology the Future of Biomarker Detection - Randox Laboratories has been supplying the world’s leading Contract Research Organisations (CRO), Pharmaceutical and Biotech companies for over 27 years with the ‘tools’ required to develop high quality pharmaceuticals…faster, safer and more economic
Biochip Array Technology the Future of Biomarker Detection

 

PRZOOM - /newswire/ - Crumlin, Antrim, United Kingdom, 2010/04/15 - Randox Laboratories has been supplying the world’s leading Contract Research Organisations (CRO), Pharmaceutical and Biotech companies for over 27 years with the ‘tools’ required to develop high quality pharmaceuticals…faster, safer and more economic.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Following decades of scientific innovation and discovery, today it is inconceivable that any new drug would be developed without simultaneously looking at a multitude of biomarkers.

This is because biomarkers are indispensable as:

• Drug efficacy markers;
• Drug toxicity markers;
• Disease predisposition markers;
• Potential targets for new drugs;
• The implements of Personalised medicine (via Pharmacogenomic profiling).

It is widely accepted that the clinical application of validated biomarkers will revolutionise medicine over the coming years. Already pharmaceuticals are being sold with Pharmacogenomic labeling information related to optimising patient selection and personal dosage, but their role in diagnostics will be even more important.

With this in mind a key focus for Randox is to take any newly discovered biomarkers from the realm of research through to clinical utility, whether in the pharmaceutical industry and clinical trials or the wider healthcare industry.
However, the process to successfully validate a biomarker is often just as lengthy and costly as for a drug candidate and key to this process is to provide accurate clinical trial results.

Randox’s Biochip Array Technology has been specifically developed to accelerate this validation process. This award-winning technology offers not only ‘diagnostic grade’ results which can be trusted, but the in-built accuracy, precision and specificity of this platform will greatly assist in study publications, clinical trial results and ultimately biomarker validation.

With a range of biochip analysers and a comprehensive selection of biomarker arrays, Randox Pharma Services (randoxpharmaservices.com) are the perfect partner for all your diagnostic and clinical trial biomarker programmes.

For full information on what Randox Pharma Services can offer please visit our new website or email pharmaservices[.]randox.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Randox Laboratories Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Biochip Array Technology the Future of Biomarker Detection

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Charlotte Jess - Randox.com 
+44(0)28 9442 2413 marketing[.]randox.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Randox Laboratories Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Randox Laboratories Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  RightITnow Ltd

Visit  JobsWare.com

Visit  S&A Capital Partner Ltd







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today